Clinical Trials Directory

Trials / Sponsors / Canadian Medical and Surgical Knowledge Translation Research Group

Canadian Medical and Surgical Knowledge Translation Research Group

Academic / Other · 11 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingCirculating Vascular Regenerative Cell Exhaustion in Individuals Without Type 2 Diabetes Who Are of South Asia
Cardiovascular Diseases Risk
—2025-01-30
CompletedLipoprotein (a) and Vascular Regenerative Cell Content
Cardiovascular Diseases, Atherosclerosis Cardiovascular Disease, Ischemic Heart Disease
—2024-10-05
RecruitingVascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)
Peripheral Vascular Diseases, Cardiovascular Disease, Type 2 Diabetes
—2024-10-01
Not Yet RecruitingFunctional Investigation of Endothelial Function and Regenerative Cell Exhaustion
Diabetes Mellitus, Type 2
—2023-11-01
UnknownSemaglutide and Vascular Regeneration
Atherosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Type 2
Phase 42023-04-29
UnknownPro-vascular Regenerative Cell Exhaustion in Women With Polycystic Ovarian Syndrome
Polycystic Ovary Syndrome
—2022-06-01
CompletedGeneralizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Dis
Cardiovascular Diseases, Atherosclerotic Cardiovascular Disease, Myocardial Infarction
—2022-03-05
CompletedThe Role of South Asian vs European Origins on Circulating Regenerative Cell Exhaustion
Diabetes, Type 1 Diabetes, Type 2 Diabetes
—2022-01-08
CompletedThe Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High
Phase 42020-09-24
UnknownA Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy
Carotid Artery Stenosis, Asymptomatic Carotid Artery Stenosis
Phase 42020-08-28
CompletedAn Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With
COVID-19, Inflammatory Response
Phase 22020-06-04